14 results
424B3
CYTH
Cyclo Therapeutics Inc - Ordinary Shares
21 Nov 23
Prospectus supplement
9:15am
transparency to product pricing, review the relationship between pricing and manufacturer patient programs, and reform government program reimbursement … price or patient reimbursement constraints, discounts, restrictions on certain product access and marketing cost disclosure and transparency measures
S-4/A
CYTH
Cyclo Therapeutics Inc - Ordinary Shares
20 Nov 23
Registration of securities issued in business combination transactions (amended)
8:50am
Congressional inquiries and proposed and enacted federal and state legislation designed to, among other things, bring more transparency to product pricing … reimbursement constraints, discounts, restrictions on certain product access and marketing cost disclosure and transparency measures, and, in some cases, designed
S-4
CYTH
Cyclo Therapeutics Inc - Ordinary Shares
7 Nov 23
Registration of securities issued in business combination transactions
4:45pm
Congressional inquiries and proposed and enacted federal and state legislation designed to, among other things, bring more transparency to product pricing, review … constraints, discounts, restrictions on certain product access and marketing cost disclosure and transparency measures, and, in some cases, designed
424B4
gb6mw7gfwaj9r3c7uu
11 Dec 20
Prospectus supplement with pricing info
1:38pm
424B4
fso ybxug
11 Dec 20
Prospectus supplement with pricing info
12:00am
- Prev
- 1
- Next